Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPortmeirion Regulatory News (PMP)

Share Price Information for Portmeirion (PMP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 237.50
Bid: 230.00
Ask: 245.00
Change: 0.00 (0.00%)
Spread: 15.00 (6.522%)
Open: 237.50
High: 237.50
Low: 237.50
Prev. Close: 237.50
PMP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

26 Apr 2022 13:49

RNS Number : 4061J
Portmeirion Group PLC
26 April 2022
 

26 April 2022

 

 

Portmeirion Group PLC

(the "Company")

 

Grant of Options

 

The Portmeirion 2012 Approved Share Option Plan and The Portmeirion 2012 Unapproved Share Option Plan (the "Option Plans") and The Portmeirion Group 2018 Deferred Incentive Share Option Plan (the "Deferred Plan")

 

As part of its long-term employee remuneration and retention incentives, the Company announces that, on 25 April 2022, the following transactions occurred for the persons discharging managerial responsibilities ("PDMRs") as shown below:

 

 

 

Option Plans number of options granted at an exercise price of 570 pence per Ordinary Share (A)

Deferred Plan number of options granted at an exercise price of £1.00 (B)

Company directors/officers:

 

 

Michael Raybould

Chief Executive

40,000

10,813

Jacqui Gale

Chief Commercial Officer

25,000

5,706

Michael Knapper

Group Operations Director

25,000

5,506

William Robedee

President of North America

25,000

7,051

David Sproston

Group Finance Director

25,000

4,279

Moira MacDonald

Group Company Secretary

11,000

-

 

Total:

151,000

33,355

Note:

(A) Grant of options under Option Plans. 

(B) Grant of new options under Deferred Plan against 2021 performance and incentive arrangements (further detail below).

The Company granted 151,000 options over Ordinary Shares to the PDMRs shown above and a further 144,500 options over Ordinary Shares to other senior managers pursuant to the Option Plans. The options are subject to the achievement of performance targets as determined by the Remuneration Committee, and as required under the Option Plans. The options granted on 25 April 2022 are normally only exercisable if the increase in the average of the Group's basic adjusted (for changes in accounting standards and exceptional items) earnings per share for each of the three years ending 31 December 2022, 31 December 2023 and 31 December 2024 is at least 20% higher than that for the year ended 31st December 2021. The calculation of basic adjusted earnings per share shall take account of the number of shares and effective tax rates at the date of grant.

In addition, the Company granted 33,355 options to Executive Directors shown above over Ordinary Shares pursuant to the Deferred Plan. In accordance with the rules of the Deferred Plan, the number of options granted is based on the gross incentive payment earned by the relevant Director in respect of the year ended 31 December 2021.

PDMR Shareholdings

 

The total number of Ordinary Shares over which each PDMR holds options and the total number of Ordinary Shares with voting rights held following this Admission is:

 

 

Total number of options

over Ordinary Shares

Total number

 of Ordinary Shares with

voting rights

Ordinary Shares percentage of Company's Ordinary Shares with voting rights

 

Michael Raybould

145,171

5,548

0.04%

Jacqui Gale

70,706

-

-

Michael Knapper

84,121

5,576

0.04%

William Robedee

 77,051

-

-

David Sproston

 88,279

1,315

0.01%

Moira MacDonald

 31,000

2,693

0.02%

     

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR).

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

_____________________________________________

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities / person closely associated with them.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Company directors/officers:

Michael Raybould

Chief Executive

Jacqui Gale

Chief Commercial Officer

Michael Knapper

Group Operations Director

William Robedee

President of North America

David Sproston

Group Finance Director

Moira MacDonald

Group Company Secretary

 

2.

Reason for the notification

a)

Position/status

See 1(a) above for all positions - all classified as PDMRs of the Company

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Portmeirion Group PLC

b)

LEI

2138003QC9J6TLZJHO70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary Shares of 5 pence each

b)

Identification code

GB0006957293

c)

Nature of the transactions

(A) Performance related, Grant of options under Option Plans. Exercise period 26 April 2025 - 24 April 2032.

(B) Grant of new options under The Portmeirion Group 2018 Deferred Incentive Share Option Plan (the "Deferred Plan").

d)

Price(s) and volume(s)

 

In respect of (A) Grant of options under Option Plans

Price at grant: Nil

 

Exercise Price: £5.70 pence per Ordinary Share

 

Volume(s)

 

 

Options over Ordinary Shares

Michael Raybould

40,000

Jacqui Gale

25,000

Michael Knapper

25,000

William Robedee

25,000

David Sproston

25,000

Moira MacDonald

11,000

In respect of (B) Grant of options under Deferred Plan

Price at grant: Nil

Exercise Price (per PDMR in respect of all options granted): £1

 

Options over Ordinary Shares

Michael Raybould

10,813

Jacqui Gale

5,706

Michael Knapper

5,506

William Robedee

7,051

David Sproston

4,279

 

e)

Aggregated information

- Aggregated volume

- Price

In respect of (A) Grant of options under Option Plans

Nil, grant of options only

In respect of (B) Grant of options under Deferred Plan

Nil, grant of options only

f)

Date of the transactions

 

In respect of (A) Grant of options under Option Plans - 25 April 2022

 

In respect of (B) Grant of options under Deferred Plan 25 April 2022

 

g)

Place of the transactions

In respect of (A) Grant of options under Option Plans - - Off-market

In respect of (B) Grant of options under Deferred Plan - Off-market

 

Name of authorised official of issuer responsible for making notification:

 

Moira MacDonald

Company Secretary to Portmeirion Group PLC

 

ENQUIRIES:

 

Portmeirion Group PLC:

Mike Raybould, Chief Executive

+44 (0) 1782 743 443

mraybould@portmeiriongroup.com

David Sproston, Group Finance Director

+44 (0) 1782 743 443

dsproston@portmeiriongroup.com

 

 

 

Hudson Sandler:

Dan de Belder

+44 (0) 207 796 4133

ddebelder@hudsonsandler.com

Nick Moore

 

nmoore@hudsonsandler.com

 

Panmure Gordon

 

 

(Nominated Adviser and Broker):

 

 

+44 (0) 207 886 2500

 

 

Freddy Crossley

Rupert Dearden

Corporate Broking

 

 

 

 

Singer Capital Markets

(Joint Broker):

 

+44 (0) 207 496 3000

 

Peter Steel / Asha Chotai

Investment Banking

 

Rachel Hayes

 

 

    

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEMFEMEESELL
Date   Source Headline
9th Aug 20197:00 amRNSExercise of Options and PDMR Shareholdings
1st Aug 20197:00 amRNSInterim Results
22nd Jul 20193:59 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSAcquisition of Nambé LLC
17th May 20194:37 pmRNSHolding(s) in Company
16th May 20191:55 pmRNSAGM Resolutions
14th May 20197:00 amRNSTrading Update
3rd May 201911:49 amRNSHolding(s) in Company
2nd May 20194:24 pmRNSHolding(s) in Company
30th Apr 20192:46 pmRNSHolding(s) in Company
5th Apr 201912:49 pmRNSHolding(s) in Company
2nd Apr 20194:46 pmRNSHolding(s) in Company
27th Mar 20193:36 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSFinal Results
4th Mar 20197:00 amRNSAppointment of Non-Executive Director
25th Feb 201911:00 amRNSAcquisition
22nd Feb 20197:00 amRNSNotice of Results
17th Jan 20197:00 amRNSTrading Update
15th Aug 20189:31 amRNSHolding(s) in Company
2nd Aug 20187:00 amRNSInterim Results
12th Jul 20187:00 amRNSTrading Update
22nd May 20186:30 pmRNSExercise of Options and PDMR Shareholdings
17th May 20181:21 pmRNSAGM Resolutions
17th May 20187:00 amRNSAGM Statement
27th Mar 20181:00 pmRNSHolding(s) in Company
27th Mar 201812:59 pmRNSHolding(s) in Company
22nd Mar 20184:47 pmRNSHolding(s) in Company
21st Mar 20185:07 pmRNSDirectorate Change
15th Mar 20187:00 amRNSFinal Results
9th Feb 20188:00 amRNSFinal Results
18th Jan 20187:00 amRNSTrading update
20th Sep 201711:43 amRNSHolding(s) in Company
11th Aug 201712:41 pmRNSExecutive Share Option Grants
9th Aug 20179:52 amRNSExercise of Options and PDMR Shareholdings
9th Aug 20178:18 amRNSExercise of Options and PDMR Shareholdings
3rd Aug 20177:00 amRNSHalf-year Report
7th Jul 20177:00 amRNSTrading Statement
20th Jun 20178:53 amRNSDirectorate Change
25th May 20172:22 pmRNSAGM Resolutions
25th May 201711:31 amRNSAGM Statement
18th May 20175:20 pmRNSExercise of Options and PDMR Shareholdings
25th Apr 20179:56 amRNSDirectorate Change
9th Mar 20177:00 amRNSFinal Results
8th Feb 20177:00 amRNSDirectorate and Company Secretary Changes
6th Feb 20179:00 amRNSAnalyst Presentation - Full Year Results
19th Jan 20177:00 amRNSTrading Update
4th Aug 20167:00 amRNSInterim results for six months ended 30 June 2016
7th Jul 20167:00 amRNSTrading Update
15th Jun 20164:32 pmRNSDirectors' Holdings
20th May 20168:26 amRNSAGM Resolutions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.